Clinical Trial Update: Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating COLAL-PRED for moderate to severe ulcerative colitis has completed. The study was sponsored by Prometheus Laboratories.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• COLAL-PRED

Snippet

Sponsor: Prometheus Laboratories | Conditions: Colitis, Ulcerative | Phase 2 | Status: COMPLETED